Levittown, PA, United States of America

John J Lafferty


Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1976-1991

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of John J Lafferty

Introduction

John J Lafferty is a notable inventor based in Levittown, PA, with a significant contribution to the field of pharmaceuticals. He holds a total of 10 patents, showcasing his innovative spirit and dedication to advancing medical science. His work primarily focuses on alpha-adrenergic receptor antagonists, which have important applications in treating various medical conditions.

Latest Patents

Lafferty's latest patents include formulations of alpha-adrenoceptor antagonists that are designed to produce alpha-adrenoceptor antagonism. These compounds are useful in creating pharmaceutical compositions that can effectively target alpha-adrenergic receptors in mammals. His research has led to the development of methods for using these antagonists, which are crucial for advancing therapeutic options in medicine.

Career Highlights

Throughout his career, John J Lafferty has worked with prominent companies such as SmithKline Beecham Corporation and SmithKline Corporation. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in pharmaceutical research.

Collaborations

Some of Lafferty's notable coworkers include Robert M DeMarinis and William Edward Bondinell. Their collaborative efforts have played a role in the development of innovative solutions in the pharmaceutical industry.

Conclusion

John J Lafferty's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new treatments and therapies, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…